首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1547589

全球衣原体感染诊断市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Chlamydia Infection Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球披衣菌感染诊断市场需求将从 2023 年的 200 万美元达到近 200 万美元的市场规模，2024-2032 年研究期间复合年增长率为 9.02%。

沙眼衣原体 (CT) 是一种革兰氏阴性细菌，可感染尿道、子宫颈和直肠的柱状上皮，以及肺部和眼睛等非生殖器区域。衣原体感染或沙眼衣原体筛检和诊断过程很简单。检测 CT 感染的程序包括尿液和分泌物检测。它包括尿液测试或分泌物测试。在尿液测试中，在实验室分析尿液样本以检查是否有感染。在分泌物检测中，医生会从子宫颈取出分泌物进行拭子进行披衣菌培养或抗原检测。

市场动态

衣原体感染盛行率的上升以及随之而来的预防和治疗未来严重程度的诊断需求推动了全球衣原体感染诊断市场的发展。全球估计报告了 9000 万沙眼衣原体病例。随着性行为的改变、缺乏预防和教育，这一数字预计还会上升。性活动的开始时间和性伴侣的数量等几个因素也会发挥作用。改进检测方法并更快获得结果预计将带来新的市场机会。主要参与者正在投资开发和推出易于负担和获取的新产品。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球衣原体感染诊断市场的每个细分市场进行了包容性评估。衣原体感染诊断行业的成长和趋势为这项研究提供了整体方法。

市场区隔

衣原体感染诊断市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按测试类型

文化测试
核酸扩增检验（NAAT）
直接萤光抗体测试
血清学检测
其他

按感染类型

生殖器衣原体感染
直肠披衣菌感染
眼衣原体感染

按最终用户

诊断（医院、专科诊所、诊断中心）
治疗学（医院药局、药局、零售药局、线上药局）

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲衣原体感染诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。披衣菌感染诊断市场的主要参与者包括 Abbott、BD、Bio-Rad Laboratories Inc、Quidel Corporation、DiaSorin SpA、AstraZeneca、Teva Pharmaceutical Industries Limited。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：衣原体感染诊断公司的竞争格局

披衣菌感染诊断市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Abbott

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Bio-Rad Laboratories Inc

公司概况
公司收入
产品
最新动态

Quidel Corporation

公司概况
公司收入
产品
最新动态

DiaSorin SpA

公司概况
公司收入
产品
最新动态

AstraZeneca

公司概况
公司收入
产品
最新动态

Teva Pharmaceutical Industries Limited

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11214593

The global demand for Chlamydia Infection Diagnostics Market is presumed to reach the market size of nearly USD XX.X Million by 2032 from USD XX.X Million in 2023 with a CAGR of 9.02% under the study period 2024-2032.

Chlamydia trachomatis (CT) is a gram-negative bacterium that infects the columnar epithelium of the urethra, cervix, and rectum, as well as non-genital areas such as the lungs and eyes. Chlamydia infection or chlamydia trachomatis screening and diagnosis process are simple. The procedures to detect CT infections include urine and discharge test. It consists of a urine test or a discharge test. In a urine test, a sample of urine is analyzed in the laboratory to check infection presence. In a discharge test, the doctor takes a swab of the discharge from the cervix for culture or antigen testing for chlamydia.

MARKET DYNAMICS

The rising prevalence of chlamydia infection and the consequent need for diagnosis to prevent and treat future severity drives the global chlamydia infection diagnostics market. Globally, an estimated 90 million cases of Chlamydia trachomatis are reported. This figure is projected to rise with changes in sexual behaviour, lack of prevention, and education. Several factors like the beginning of the sexual activity and the number of sexual partners also play a role. Improving detection methods with faster results is expected to bring new market opportunities. Key players are investing in the development and introduction of new products which are easily affordable and accessible.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Chlamydia Infection Diagnostics. The growth and trends of Chlamydia Infection Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Chlamydia Infection Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Culture Test
Nucleic Acid Amplification Test (NAAT)
Direct Fluorescent Antibody Test
Serology Test
Other

By Type of Infections

Genital Chlamydia Infection
Rectal Chlamydia Infection
Ocular Chlamydia Infection

By End User

Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Chlamydia Infection Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Chlamydia Infection Diagnostics market include Abbott, BD, Bio-Rad Laboratories Inc, Quidel Corporation, DiaSorin SpA, AstraZeneca, Teva Pharmaceutical Industries Limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CHLAMYDIA INFECTION DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Type of Infections
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data
5.3. Analysis By Test Type
5.4. Culture Test Historic and Forecast Sales By Regions
5.5. Nucleic Acid Amplification Test (NAAT) Historic and Forecast Sales By Regions
5.6. Direct Fluorescent Antibody Test Historic and Forecast Sales By Regions
5.7. Serology Test Historic and Forecast Sales By Regions
5.8. Other Historic and Forecast Sales By Regions

6. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY TYPE OF INFECTIONS

6.1. Overview By Type of Infections
6.2. Historical and Forecast Data
6.3. Analysis By Type of Infections
6.4. Genital Chlamydia Infection Historic and Forecast Sales By Regions
6.5. Rectal Chlamydia Infection Historic and Forecast Sales By Regions
6.6. Ocular Chlamydia Infection Historic and Forecast Sales By Regions

7. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data
7.3. Analysis By End User
7.4. Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Historic and Forecast Sales By Regions
7.5. Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Historic and Forecast Sales By Regions

8. GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CHLAMYDIA INFECTION DIAGNOSTICS COMPANIES

9.1. Chlamydia Infection Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CHLAMYDIA INFECTION DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. BD
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bio-Rad Laboratories Inc
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Quidel Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. DiaSorin SpA
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. AstraZeneca
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Teva Pharmaceutical Industries Limited
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Test Type (USD MN)
Culture Test Market Sales By Geography (USD MN)
Nucleic Acid Amplification Test (NAAT) Market Sales By Geography (USD MN)
Direct Fluorescent Antibody Test Market Sales By Geography (USD MN)
Serology Test Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Analysis By Type of Infections (USD MN)
Genital Chlamydia Infection Market Sales By Geography (USD MN)
Rectal Chlamydia Infection Market Sales By Geography (USD MN)
Ocular Chlamydia Infection Market Sales By Geography (USD MN)
Analysis By End User (USD MN)
Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Market Sales By Geography (USD MN)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Market Sales By Geography (USD MN)
Global Chlamydia Infection Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Chlamydia Infection Diagnostics Report
Market Research Process
Market Research Methodology
Global Chlamydia Infection Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Test Type
Market Attractiveness Analysis By Type of Infections
Market Attractiveness Analysis By End User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Test Type (USD MN)
Culture Test Market Sales By Geography (USD MN)
Nucleic Acid Amplification Test (NAAT) Market Sales By Geography (USD MN)
Direct Fluorescent Antibody Test Market Sales By Geography (USD MN)
Serology Test Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Market Analysis By Type of Infections (USD MN)
Genital Chlamydia Infection Market Sales By Geography (USD MN)
Rectal Chlamydia Infection Market Sales By Geography (USD MN)
Ocular Chlamydia Infection Market Sales By Geography (USD MN)
Global Market Analysis By End User (USD MN)
Diagnostics (Hospitals, Specialty Clinics, Diagnostics Centre) Market Sales By Geography (USD MN)
Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies, Online Pharmacies) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis